Work

Does HRCT pattern influence the effect of nintedanib in patients with progressive fibrosing interstitial lung diseases?

Year: 2021

Type: conference-paper

Source: Pneumologie

DOI: 10.1055/s-0041-1723316

Authors: J Behr, K K Brown, S LF Walsh, A Devaraj, J W Song, W A Wuyts, C Valenzuela, R G Goeldner, S Stowasser, R Schlenker-Herceg, A U Wells

Institutions: Asklepios Fachkliniken München-Gauting, Ludwig-Maximilians-Universität München, National Jewish Health, Imperial College London, Royal Brompton & Harefield NHS Foundation Trust, Asan Medical Center, University of Ulsan, Universitair Ziekenhuis Leuven, Hospital Universitario de La Princesa, Boehringer Ingelheim (Germany), Boehringer Ingelheim (United States)

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387954642

FWCI:

Cites:

Cited by:

Related to: 10